# C_2021452EN.01001802.xml

| 8.11.2021 | EN | Official Journal of the European Union | C 452/18 |
| --- | --- | --- | --- |

8.11.2021

EN

Official Journal of the European Union

C 452/18

---

Judgment of the General Court of 15 September 2021 — Laboratoire Pareva and Biotech3D v Commission

(Joined Cases T-337/18 and T-347/18) (1)

(Biocidal products - Active substance PHMB (1415; 4.7) - Refusal of approval for product-types 1, 5 and 6 - Conditional approval for product-types 2 and 4 - Risks to human health and the environment - Regulation (EU) No 528/2012 - Article 6(7)(a) and (b) of Delegated Regulation (EU) No 1062/2014 - Harmonised classification of the active substance under Regulation (EC) No 1272/2008 - Prior consultation of the ECHA - Manifest error of assessment - Read-across - Right to be heard)

(2021/C 452/17)

Language of the case: English

Parties

Applicant in cases T-337/18 and T-347/18: Laboratoire Pareva (Saint-Martin-de-Crau, France) (represented by: K. Van Maldegem, S. Englebert, P. Sellar and M. Grunchard, lawyers)

Applicant in case T-347/18: Biotech3D Ltd & Co. KG (Gampern, Austria) (represented by: K. Van Maldegem, S. Englebert, P. Sellar and M. Grunchard, lawyers)

Defendant: European Commission (represented by: R. Lindenthal and K. Mifsud-Bonnici, acting as Agents)

Interveners in support of the defendant: French Republic (represented by: A.-L. Desjonquères, J. Traband, E. Leclerc and W. Zemamta, acting as Agents), European Chemicals Agency (ECHA) (represented by: M. Heikkilä, C. Buchanan and T. Zbihlej, acting as Agents)

Re:

Applications pursuant to Article 263 TFEU seeking annulment of, in Case T 337/18, Commission Implementing Decision (EU) 2018/619 of 20 April 2018 not approving PHMB (1415; 4.7) as an existing active substance for use in biocidal products of product-types 1, 5 and 6 (OJ 2018 L 102, p. 21), and, in Case T 347/18, Commission Implementing Regulation (EU) 2018/613 of 20 April 2018 approving PHMB (1415; 4.7) as an existing active substance for use in biocidal products of product-types 2 and 4 (OJ 2018 L 102, p. 1).

Operative part of the judgment

The Court:

| 1. | Joins Cases T-337/18 and T-347/18 for the purposes of the present judgment; |
| --- | --- |

1.

Joins Cases T-337/18 and T-347/18 for the purposes of the present judgment;

| 2. | Dismisses the actions; |
| --- | --- |

2.

Dismisses the actions;

| 3. | In Case T-337/18, orders Laboratoire Pareva to bear its own costs and to pay those incurred by the European Commission, including those incurred in the proceedings for interim measures registered under number T-337/18 R and T-337/18 R II; |
| --- | --- |

3.

In Case T-337/18, orders Laboratoire Pareva to bear its own costs and to pay those incurred by the European Commission, including those incurred in the proceedings for interim measures registered under number T-337/18 R and T-337/18 R II;

| 4. | In Case T-347/18, orders Laboratoire Pareva and Biotech3D Ltd & Co. KG to bear their own costs and to pay those incurred by the Commission, including those incurred in the proceedings for interim measures registered under number T-347/18 R, and orders Laboratoire Pareva also to pay the costs incurred in the proceedings for interim measures registered under number T-347/18 R II; |
| --- | --- |

4.

In Case T-347/18, orders Laboratoire Pareva and Biotech3D Ltd & Co. KG to bear their own costs and to pay those incurred by the Commission, including those incurred in the proceedings for interim measures registered under number T-347/18 R, and orders Laboratoire Pareva also to pay the costs incurred in the proceedings for interim measures registered under number T-347/18 R II;

| 5. | Orders the French Republic and the European Chemicals Agency (ECHA) to each bear their own costs. |
| --- | --- |

5.

Orders the French Republic and the European Chemicals Agency (ECHA) to each bear their own costs.

---

(1)  OJ C 285, 13.8.2018.

---